Revenue Breakdown
Composition ()
No data
Revenue Streams
Profitability & Margins
Evaluating the bottom line, Novavax Inc maintains a gross margin of 84.98%. This metric reflects the company's pricing power and manufacturing efficiency. Further down the income statement, the operating margin stands at 10.22%, while the net margin is 11.91%. These profitability ratios, combined with a Return on Equity (ROE) of N/A, provide a clear picture of how effectively NVAX converts its operational activities into shareholder value.
Comparative Benchmarking
In the context of the broader market, NVAX competes directly with industry leaders such as ANIP and NRIX. With a market capitalization of $1.65B, it holds a significant position in the sector. When comparing efficiency, NVAX's gross margin of 84.98% stands against ANIP's 50.26% and NRIX's 100.00%. Such benchmarking helps identify whether Novavax Inc is trading at a premium or discount relative to its financial performance.
